Cliniques universitaires Saint-Luc
Brussels, 1200, Belgium
NCT Number: NCT03966196
The objective is to verify that there is a decrease in the pulsed oxygen saturation with the digital sensor. That is, the drop in oxygen saturation in COPD patients during inhalation is real and not due to an artifact of the measuring tool, because oximeters need a quality pulsatile signal to properly measure oxygen saturation
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Brussels, 1200, Belgium
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
healthy arm
Inclusion criteria
Exclusion criteria
COPD Arm
Inclusion criteria
Exclusion criteria
The subjects selected are selected on a voluntary basis among the patients coming to the pulmonary consultation. They have Chronic Obstructive Pulmonary Disease.
Measurements during deep inspiration of oxygen saturation with pulse oximeter and finger pressure with pressure cuff
Time frame: from the intervention to 3 minutes after the start of the intervention
saturation is measured in percentage (SPO2)
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Other
Validation and Characterization of Signal Decrease on an Oximeter in Chronic Obstructive Pulmonary Disease
Acronym: OXYMETRE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06149494
COPD, COPD Exacerbation Acute
London, United Kingdom
View Trial DetailsNCT05962645
COPD, Chronic Disease
Miami, Florida, United States
View Trial DetailsNCT03229473
COPD, Chronic Disease
Hamilton, Ontario, Canada
View Trial DetailsNCT05222295
COPD, Chronic Disease
Istanbul, Zeytinburnu, Turkey (Türkiye)
View Trial Details